Serum MicroRNA profiles serve as novel biomarkers for the diagnosis of alzheimer's disease

Disease Markers

Volumn 2015, Issue , 2015, Pages

  Dong, Hui ^a,b   Li, Jialu ^a,c   Huang, Lei ^a   Chen, Xi ^a   Li, Donghai ^a   Wang, Tao ^d,e   Hu, Caiyou ^f   Xu, Jun ^g   Zhang, Chunni ^a,b   Zen, Ke ^a   Xiao, Shifu ^d,e   Yan, Qiao ^a   Wang, Cheng ^a,b   Zhang, Chen Yu ^a  

^a NANJING UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e SHANGHAI JIAO TONG UNIVERSITY   (China)

^f Guangxi Zhuangzu Zizhiqu Jiangbin Yiyuan   (China)

^g THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 143; MICRORNA 146A; MICRORNA 31; MICRORNA 93; UNCLASSIFIED DRUG; MIRN143 MICRORNA, HUMAN; MIRN146 MICRORNA, HUMAN; MIRN31 MICRORNA, HUMAN; MIRN93 MICRORNA, HUMAN;

AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN TISSUE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HYDROLYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; BLOOD; COGNITIVE DEFECT; DEMENTIA, VASCULAR; DIFFERENTIAL DIAGNOSIS; GENETICS; PROCEDURES; RECEIVER OPERATING CHARACTERISTIC; SEQUENCE ANALYSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOMARKERS; COGNITIVE DYSFUNCTION; DEMENTIA, VASCULAR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MICRORNAS; ROC CURVE; SEQUENCE ANALYSIS, RNA;

EID: 84930959713     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2015/625659     Document Type: Article

References (42)

1. R. Brookmeyer, E. Johnson, K. Ziegler-Graham, and H. M. Arrighi, "Forecasting the global burden of Alzheimer's disease," Alzheimer's and Dementia, vol. 3, no. 3, pp. 186-191, 2007.
2. G.McKhann, D. Drachman, and M. Folstein, "Clinical diagnosis of Alzheimer's disease: report of theNINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer's disease," Neurology, vol. 34, no. 7, pp. 939-944, 1984.
3. D. S. Knopman, S. T. DeKosky, J. L. Cummings et al., "Practice parameter: diagnosis of dementia (an evidence-based review). Report of theQuality Standards Subcommittee of the American Academy of Neurology," Neurology, vol. 56, no. 9, pp. 1143-1153, 2001.
4. S. S. Simon, J. E. Yokomizo, and C. M. C. Bottino, "Cognitive intervention in amnesticMild Cognitive Impairment: a systematic review,"Neuroscience and Biobehavioral Reviews, vol. 36,no. 4, pp. 1163-1178, 2012.
5. R. C. Petersen, G. E. Smith, S. C. Waring, R. J. Ivnik, E. G. Tangalos, and E. Kokmen, "Mild cognitive impairment: clinical characterization and outcome," Archives of Neurology, vol. 56, no. 3, pp. 303-308, 1999.
6. V. Hachinski, C. Iadecola, R. C. Petersen et al., "National Institute ofNeurologicalDisorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards," Stroke, vol. 37, no. 9, pp. 2220-2241, 2006.
7. D. S. Knopman, J. E. Parisi,B.F.Boeve et al., "Vasculardementia in a population-based autopsy study," Archives of Neurology, vol. 60, no. 4, pp. 569-575, 2003.
8. D. P. Bartel, "MicroRNAs: genomics, biogenesis, mechanism, and function," Cell, vol. 116, no. 2, pp. 281-297, 2004.
9. X. Chen, Y. Ba, L.Ma et al., "Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases," Cell Research, vol. 18, no. 10, pp. 997-1006, 2008.
10. C. Fang, D.-X. Zhu, H.-J. Dong et al., "Serum microRNAs are promising novel biomarkers for diffuse large B cell lymphoma," Annals of Hematology, vol. 91, no. 4, pp. 553-559, 2012.
11. P. S. Mitchell, R. K. Parkin, E. M. Kroh et al., "Circulating microRNAs as stable blood-based markers for cancer detection," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 30, pp. 10513-10518, 2008.
12. H. Mizuno, A. Nakamura, Y. Aoki et al., "Identification of muscle-specific MicroRNAs in serum of muscular dystrophy animal models: Promising novel blood-based markers for muscular dystrophy," PLoS ONE, vol. 6, no. 3,Article IDe18388, 2011.
13. H. Geekiyanage, G. A. Jicha, P. T. Nelson, and C. Chan, "Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease," Experimental Neurology, vol. 235, no. 2, pp. 491-496, 2012.
14. L. M. Bekris, F. Lutz, T. J. Montine et al., "MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma," Biomarkers, vol. 18, no. 5, pp. 455-466, 2013.
15. P. Kumar, Z. Dezso, C. MacKenzie et al., "Circulating miRNA Biomarkers for Alzheimer's Disease," PLoS ONE, vol. 8, no. 7, Article ID e69807, 2013.
16. T. Kiko, K. Nakagawa, T. Tsuduki, K. Furukawa, H. Arai, and T. Miyazawa, "MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease," Journal of Alzheimer's Disease, vol. 39, no. 2, pp. 253-259, 2014.
17. C.Y.Wu, C.Wang,X.C.Guanet al., "Diagnostic andprognostic implications of a serummiRNApanel in oesophageal squamous cell carcinoma," PLoSONE, vol. 9, no. 3,Article IDe92292, 2014.
18. M. C. Irizarry, "Biomarkers of Alzheimer disease in plasma," NeuroRx, vol. 1, no. 2, pp. 226-234, 2004.
19. S. S. Hébert, K. Horré, L. Nicolaï et al., "Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 17, pp. 6415-6420, 2008.
20. W. J. Lukiw, "Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus," NeuroReport, vol. 18, no. 3, pp. 297-300, 2007.
21. W. J. Lukiw, Y. Zhao, and J. G. Cui, "An NF-κB-sensitive micro RNA-146a-mediated inflammatory circuit in alzheimer disease and in stressed human brain cells," Journal of Biological Chemistry, vol. 283, no. 46, pp. 31315-31322, 2008.
22. J. Nunez-Iglesias, C. C. Liu, T. E. Morgan, C. E. Finch, and X. J. Zhou, "Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation," PLoS ONE, vol. 5, no. 2, Article ID e8898, 2010.
23. J. I. Satoh, "MicroRNAs and their therapeutic potential for human diseases: aberrant microRNA expression in Alzheimer's disease brains," Journal of Pharmacological Sciences, vol. 114, no. 3, pp. 269-275, 2010.
24. M. Shioya, S.Obayashi, H. Tabunoki et al., "Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3," Neuropathology and Applied Neurobiology, vol. 36, no. 4, pp. 320-330, 2010.
25. W.-X.Wang,B.W.Rajeev, A. J. Stromberg et al., "The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1," Journal of Neuroscience, vol. 28, no. 5, pp. 1213-1223, 2008.
26. J. P. Cogswell, J. Ward, I. A. Taylor et al., "Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways," Journal of Alzheimer's Disease, vol. 14, no. 1, pp. 27-41, 2008.
27. X. Chen, Z. Hu, W. Wang et al., "Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis," International Journal of Cancer, vol. 130, no. 7, pp. 1620-1628, 2012.
28. J. Wang, J. Chen, P. Chang et al., "MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel bloodbased biomarkers of disease," Cancer Prevention Research, vol. 2, no. 9, pp. 807-813, 2009.
29. K. E. Resnick, H. Alder, J. P. Hagan, D. L. Richardson, C. M. Croce, and D. E. Cohn, "The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform," Gynecologic Oncology, vol. 112, no. 1, pp. 55-59, 2009.
30. E.K.O.Ng,W.W. S. Chong,H. Jinet al., "Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening," Gut, vol. 58, no. 10, pp. 1375-1381, 2009.
31. S. Gilad, E. Meiri, Y. Yogev et al., "Serum microRNAs are promising novel biomarkers," PLoS ONE, vol. 3, no. 9, Article ID e3148, 2008.
32. L. Tan, J.-T. Yu, M.-S. Tan et al., "Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease," Journal of Alzheimer's Disease, vol. 40, no. 4, pp. 1017-1027, 2014.
33. K. H. Chang, P.Mestdagh, J. Vandesompele,M. J. Kerin, and N. Miller, "MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer," BMC Cancer, vol. 10, article 173, 2010.
34. C. Yang, C. Wang, X. Chen et al., "Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas," International Journal of Cancer, vol. 132, no. 1, pp. 116-127, 2013.
35. R. Liu, C. Zhang, Z. Hu et al., "A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis," European Journal of Cancer, vol. 47, no. 5, pp. 784-791, 2011.
36. B. Dubois, H. H. Feldman, C. Jacova et al., "Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDSADRDA criteria," The Lancet Neurology, vol. 6, no. 8, pp. 734-746, 2007.
37. N. Xu, F. Meisgen, L. M. Butler et al., "MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40," The Journal of Immunology, vol. 190, no. 2, pp. 678-688, 2013.
38. J. Hu, C. Chen, Q. Liu et al., "The role of miR-31/FIH1 pathway in TGFbeta-induced liver fibrosis," Clinical Science (London). In press.
39. Q. Zhang, S. K. Padi, D. J. Tindall, and B. Guo, "Polycomb protein EZH2 suppresses apoptosis by silencing the proapoptotic miR-31," Cell Death and Disease, vol. 5, no. 10, p. e1486, 2014.
40. E. Fabbri, M. Borgatti, G. Montagner et al., "Expression of microRNA-93 and interleukin-8 during Pseudomonas aeruginosa-mediated induction of proinflammatory responses," The American Journal of Respiratory Cell andMolecular Biology, vol. 50, no. 6, pp. 1144-1155, 2014.
41. M. Rouse, R. Rao, M. Nagarkatti, and P. S. Nagarkatti, "3,3-diindolylmethane ameliorates experimental autoimmune encephalomyelitis by promoting cell cycle arrest and apoptosis in activated T cells through microRNA signaling pathways," Journal of Pharmacology and Experimental Therapeutics, vol. 350, no. 2, pp. 341-352, 2014.
42. G.Wang, B. C. H. Kwan, F.M.M. Lai, K.M. Chow, P. K. T. Li, and C. C. Szeto, "Urinary miR-21, miR-29, and miR-93: novel biomarkers of fibrosis," American Journal of Nephrology, vol. 36, no. 5, pp. 412-418, 2012.